nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse Metabolic Effects of Diltiazem Treatment During Diabetic Cardiomyopathy
|
Parriman, Matt |
|
2019 |
24 |
2 |
p. 193-203 |
artikel |
2 |
Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge
|
Choi, In Suck |
|
2019 |
24 |
2 |
p. 120-129 |
artikel |
3 |
Approaches to Direct Oral Anticoagulant Selection in Practice
|
Paravattil, Bridget |
|
2019 |
24 |
2 |
p. 95-102 |
artikel |
4 |
Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock
|
Lewis, Tyler C. |
|
2019 |
24 |
2 |
p. 130-138 |
artikel |
5 |
Comparison of Efficacy between Ramipril and Carvedilol on Limiting the Expansion of Abdominal Aortic Aneurysm in Mouse Model
|
Park, Sang Min |
|
2019 |
24 |
2 |
p. 172-181 |
artikel |
6 |
De-Escalation of Antiplatelet Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials
|
Kheiri, Babikir |
|
2019 |
24 |
2 |
p. 153-159 |
artikel |
7 |
Effect of Platelet GPIIb/IIIa Receptor Blockade With MK383 on Infarct Size and Myocardial Blood Flow in a Canine Reocclusion Model
|
Kingma, John G. |
|
2019 |
24 |
2 |
p. 182-192 |
artikel |
8 |
Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study
|
Villacorta, Aline Sterque |
|
2019 |
24 |
2 |
p. 139-145 |
artikel |
9 |
Factors Associated With the Concomitant Use of Cardiovascular Drugs and Dietary Herbal Products: A Cross-Sectional Study
|
Aykan, Duygun Altıntaş |
|
2019 |
24 |
2 |
p. 146-152 |
artikel |
10 |
Sodium Nitrite–Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis
|
Jones, Daniel A. |
|
2019 |
24 |
2 |
p. 113-119 |
artikel |
11 |
The Role of Direct Oral Anticoagulants in Patients With Coronary Artery Disease
|
Turgeon, Ricky D. |
|
2019 |
24 |
2 |
p. 103-112 |
artikel |
12 |
Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents
|
Qiu, Bo |
|
2019 |
24 |
2 |
p. 160-171 |
artikel |